Pfizer Inc.’s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug ...
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...
Activist investor Starboard Value has taken a stake of about $1 billion in Pfizer and wants the U.S. drug giant to make ...
Although it has been plagued by multiple issues, including falling sales with lower demand for its Covid-19 products, and an ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...
Analysis
MarketBeat on MSN19hAnalysis
4 Reasons Pfizer Could Be a Value Play You Can't Miss
Pfizer is in value territory, trading at just 10.74X forward earnings with a 5.88% annual dividend yield and over $10 billion in cash after selling $2.4 billion of its HLN position.
Within international sales, emerging markets are a major contributor ... indicative of a strong market presence. Revenue ...
Bourla and Shantanu Narayen, Pfizer's lead independent director and Adobe Systems CEO, will hold talks with Starboard chief ...
No large pharma company has traversed this decade's ups and downs quite like Pfizer. | No large pharma company has traversed ...
Pharmaceutical giant Pfizer is set to reduce its workforce in Ireland as it faces ongoing challenges in the wake of the COVID ...